mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |